# Robert Van Grouw Dairy – FDA 483, Jul 21, 2022

Source: https://www.keypedia.com/records/483/robert-van-grouw-dairy/7e5caa9f-7474-4923-8051-09e50a8c4d11

> FDA 483 for Robert Van Grouw Dairy on July 21, 2022. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert Van Grouw Dairy
- Inspection Date: 2022-07-21
- Product Type: veterinary
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of Robert Van Grouw Dairy in Visalia, CA, revealed two significant observations. The firm was cited for extralabel drug use that resulted in a dairy cow having a violative tissue residue of Desfuroylceftiofur, exceeding the established tolerance level. Additionally, the inspection found that the dairy failed to maintain complete treatment records for its animals, lacking critical information such as treatment dates, total drug dosage, route of administration, and the person who administered the drug.

## Related Officers

- [Scott J. Matsuda](https://www.keypedia.com/people/scott-j-matsuda/eee79fae-a999-4cdc-aeac-092a5f79d92c)

Company: https://www.keypedia.com/companies/robert-van-grouw-dairy/736c6d81-0618-4c0a-9fae-de84c32c6d84

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6